These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. Ito K, Fujita N, Kanno A, Matsubayashi H, Okaniwa S, Nakahara K, Suzuki K, Enohara R, Post-ERCP Pancreatitis Prevention by Pancreatic Duct Stenting Research Group (PEP Study Group), Japan. Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981 [Abstract] [Full Text] [Related]
5. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. Takenaka M, Fujita T, Sugiyama D, Masuda A, Shiomi H, Sugimoto M, Sanuki T, Hayakumo T, Azuma T, Kutsumi H. J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185 [Abstract] [Full Text] [Related]
6. Need for pancreatic stenting after sphincterotomy in patients with difficult cannulation. Nakahara K, Okuse C, Suetani K, Michikawa Y, Kobayashi S, Otsubo T, Itoh F. World J Gastroenterol; 2014 Jul 14; 20(26):8617-23. PubMed ID: 25024617 [Abstract] [Full Text] [Related]
8. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Sofuni A, Maguchi H, Mukai T, Kawakami H, Irisawa A, Kubota K, Okaniwa S, Kikuyama M, Kutsumi H, Hanada K, Ueki T, Itoi T. Clin Gastroenterol Hepatol; 2011 Oct 14; 9(10):851-8; quiz e110. PubMed ID: 21749851 [Abstract] [Full Text] [Related]
9. Into which Region Should a Prophylactic Pancreatic Stent Be Inserted? A Propensity Score Matching Analysis. Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Nakamura J, Takasumi M, Hashimoto M, Kato T, Hikichi T, Ohira H. J Gastrointestin Liver Dis; 2020 Sep 09; 29(3):399-405. PubMed ID: 32830824 [Abstract] [Full Text] [Related]
10. The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study. Zhang C, Yang YL, Ma YF, Zhang HW, Li JY, Lin MJ, Shi LJ, Qi CC. BMC Gastroenterol; 2017 Oct 18; 17(1):108. PubMed ID: 29047328 [Abstract] [Full Text] [Related]
11. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis. Shi QQ, Ning XY, Zhan LL, Tang GD, Lv XP. World J Gastroenterol; 2014 Jun 14; 20(22):7040-8. PubMed ID: 24944500 [Abstract] [Full Text] [Related]
12. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Fan JH, Qian JB, Wang YM, Shi RH, Zhao CJ. World J Gastroenterol; 2015 Jun 28; 21(24):7577-83. PubMed ID: 26140006 [Abstract] [Full Text] [Related]
13. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Lee TH, Moon JH, Choi HJ, Han SH, Cheon YK, Cho YD, Park SH, Kim SJ. Gastrointest Endosc; 2012 Sep 28; 76(3):578-85. PubMed ID: 22771100 [Abstract] [Full Text] [Related]
15. Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study. Hakuta R, Hamada T, Nakai Y, Isayama H, Kogure H, Takahara N, Mizuno S, Yagioka H, Togawa O, Matsubara S, Ito Y, Yamamoto N, Tada M, Koike K. J Gastroenterol Hepatol; 2019 Jun 28; 34(6):1116-1122. PubMed ID: 30152138 [Abstract] [Full Text] [Related]
18. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. Shin SH, So H, Cho S, Kim N, Baik GH, Lee SK, Park DH. J Gastroenterol Hepatol; 2020 Jul 28; 35(7):1201-1207. PubMed ID: 31830336 [Abstract] [Full Text] [Related]